We are live on ! Find out more
TCP

Tyndall Capital Partners Portfolio holdings

AUM $452K
1-Year Est. Return 26.52%
This Fund
S&P 500
This Quarter Est. Return
+12.61%
1 Year Est. Return
+26.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$427K
AUM Growth
+$47.8K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYCN icon
1
Cyclerion Therapeutics
CYCN
$19.4M
$427K 100%
164,777

Similar funds

Tyndall Capital Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Tyndall Capital Partners held 1 position worth $427K, up 13% from $379K the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 0%. Tyndall Capital Partners opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Tyndall Capital Partners's ten largest holdings make up 100% of its $427K portfolio in Q3 2024.
  • Tyndall Capital Partners opened 0 new positions and closed 0 in Q3 2024.
  • Tyndall Capital Partners's portfolio value rose 13% quarter-over-quarter to $427K.

Based on Tyndall Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.